Highlights From EASL 2019

April 10-14, 2019; Vienna, Austria
Expert faculty members summarize key studies on hepatitis C treatment and elimination, hepatitis B treatment, NASH/NAFLD clinical impact, and NASH treatment studies from this important annual conference.
Nancy Reau, MD
Zobair Younossi Headshot
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
Stefan Zeuzem, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.01 MB
Released: April 30, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by:
AbbVie
Gilead Sciences

Related Content

Download free expert-authored slides on the clinical interplay of HCV and COVID-19 coinfection and the impact of the COVID-19 pandemic on access to HCV care and treatment

Ricardo Franco, MD Stacey Trooskin, MD, PhD Released: October 7, 2020

Gain experts insight with this CCO commentary on key hepatitis C elimination studies presented at the Digital International Liver Conference 2020

Nancy Reau, MD Released: October 2, 2020

Downloadable slides from CCO expert, Dr. Alain H. Litwin, on integrating HCV and HIV prevention and care strategies into addiction care settings

Alain H. Litwin, MD Released: September 18, 2020

Dr. Stefan Zeuzem discusses new viral hepatitis data reported at the 2020 Digital International Liver Congress, in the CCO Infectious Disease podcast

Stefan Zeuzem, MD Released: September 14, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue